Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.4782
-0.0155 (-3.14%)
Sep 10, 2026, 10:58 AM EDT - Market open
Impact BioMedical Market Cap
Impact BioMedical has a market cap or net worth of $51.56 million as of September 10, 2026. Its market cap has increased by 557.14% in one year.
Market Cap
51.56M
Enterprise Value
51.55M
1-Year Change
557.14%
Ranking
Category
Stock Price
$0.48
ChartMarket Cap Chart
Since the IPO on September 16, 2024, Impact BioMedical's market cap has increased from $34.49M to $51.56M, an increase of 49.48%. That is a compound annual growth rate of 22.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 51.56M | -2.41% |
| Dec 31, 2025 | 52.83M | 216.73% |
| Dec 31, 2024 | 16.68M | -51.64% |
| Sep 16, 2024 | 34.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Elicio Therapeutics | 61.63M |
| MiNK Therapeutics | 60.11M |
| eXoZymes | 59.86M |
| Xilio Therapeutics | 59.12M |
| ImageneBio | 57.78M |
| Seres Therapeutics | 55.87M |
| Annovis Bio | 55.60M |
| Hyperion DeFi | 55.48M |